1-9 of 9
Marybeth Nelson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II Trial of Combination of Bortezomib and Rituximab in Relapsed and/or Refractory Waldenstrom Macroglobulinemia

Irene M. Ghobrial, M.D., Jeffrey Matous, MD, Swaminathan Padmanabhan, MD, Ashraf Badros, MD, Robert Schlossman, MD, Stacey Chuma, RN, Renee Leduc1, Marybeth Nelson, PA, Kelly O’Connor, Amy Sam, Brianna Harris, Jacob Soumerai, Diane Warren, Ann Birner, Nikhil Munshi, MD, Steven P. Treon, MD, PhD, Kenneth C. Anderson, MD, Paul Richardson, MD
Journal: Blood
Blood (2008) 112 (11): 832.
https://doi.org/10.1182/blood.V112.11.832.832
Published: 2008
Journal Articles

Final Results of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed and/or Refractory Waldenstrom Macroglobulinemia (WM).

Irene M. Ghobrial, M.D., Xavier Leleu, MD, PhD, Nancy Rubin, MD, Wanling Xie, Fangxin Hong, Stacey Chuma, RN, Renee Leduc, Marybeth Nelson, PA, Kelly O’Connor, Amy Sam, Brianna Harris, Diane Warren, Peter Sportelli, Steven P. Treon, MD, PhD, Edie Weller, PhD, Kenneth C. Anderson, MD, Paul G. Richardson, MD
Journal: Blood
Blood (2008) 112 (11): 1010.
https://doi.org/10.1182/blood.V112.11.1010.1010
Published: 2008
Journal Articles

Phase II Trial of the mTOR Inhibitor RAD001 in Relapsed and/or Refractory Waldenstrom Macroglobulinemia: The Dana Farber Cancer Institute Experience.

Irene M. Ghobrial, M.D., Stacey Chuma, RN, Amy Sam, Renee Leduc, Marybeth Nelson, PA, Kelly O’Connor, Brianna Harris, Jacob Soumerai, Diane Warren, Eric Jacobsen, MD, Daniel DeAngelo, MD, PhD, Kenneth C. Anderson, MD, Paul G. Richardson, MD, Thomas E. Witzig, MD, Steven P. Treon, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 1011.
https://doi.org/10.1182/blood.V112.11.1011.1011
Published: 2008
Journal Articles

Phase I Trial of CCI-779 (Temsirolimus) and Weekly Bortezomib in Relapsed and/or Refractory Multiple Myeloma

Irene M. Ghobrial, M.D., Nikhil Munshi, MD, Robert Schlossman, MD, Stacey Chuma, RN, Renee Leduc, Marybeth Nelson, PA, Amy Sam, Kelly O’Connor, Brianna Harris, Diane Warren, Akari M. Dollard, Jacob Laubach, MD, Ravi Vij, MD, Erica Campagnaro, MD, Ann Birner, Virginia Dixon-Lipscomb, Kenneth C. Anderson, Paul G. Richardson
Journal: Blood
Blood (2008) 112 (11): 3696.
https://doi.org/10.1182/blood.V112.11.3696.3696
Published: 2008
Journal Articles

Imatinib Mesylate (Gleevec®) Produces Responses in Patients with Relapsed/Refractory Waldenstrom’s Macroglobulinemia.

Jacob D. Soumerai, Kelly E. O’Connor, Leukothea M. Ioakimidis, MS, Christopher J. Patterson, Bryan T. Ciccarelli, Renee Leduc, Zachary R. Hunter, Marybeth Nelson, PA-C, Aldo M. Roccaro, MD, Xavier Leleu, MD, Evdoxia Hatjiharissi, MD, Sophia Adamia, PhD, Lian Xu, Irene M. Ghobrial, MD, Steven P. Treon, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 2575.
https://doi.org/10.1182/blood.V110.11.2575.2575
Published: 2007
Journal Articles

Serum Immunoglobulin Free Light Chain (sFLC) Is a Sensitive Marker of Response in Waldenstrom Macroglobulinemia (WM).

Xavier Leleu, MD, Evdoxia Hatjiharissi, MD, Aldo M. Roccaro, MD, Anne-Sophie Moreau, MD, Renee Leduc, Marybeth Nelson, Mena Farag, Steven P. Treon, MD, Irene M. Ghobrial, MD
Journal: Blood
Blood (2007) 110 (11): 1486.
https://doi.org/10.1182/blood.V110.11.1486.1486
Published: 2007
Journal Articles

Phase II Trial of Perifosine (KRX-0401) in Relapsed and/or Refractory Waldenström Macroglobulinemia: Preliminary Results.

Irene M. Ghobrial, Xavier Leleu, Nancy Rubin, Marybeth Nelson, Renee Leduc, Diane Warren, Jana Allen, Sue Lovecchio, Jacob Soumerai, Peter Sportelli, Robert Birch, Craig Henderson, Steven P. Treon, Paul Richardson, Kenneth C. Anderson
Journal: Blood
Blood (2007) 110 (11): 4493.
https://doi.org/10.1182/blood.V110.11.4493.4493
Published: 2007
Journal Articles

Phase II Trial of Combination of Bortezomib and Rituximab in Relapsed and/or Refractory Waldenstrom Macroglobulinemia: Preliminary Results.

Irene M. Ghobrial, Swaminathan Padmanabhan, Ashraf Badros, Marybeth Nelson, Renee Leduc, Xavier Leleu, Diane Warren, Jacob Soumerai, Ann Birner, Robert Schlossman, Nikhil Munshi, Paul Richardson, Steven P. Treon, Kenneth C. Anderson
Journal: Blood
Blood (2007) 110 (11): 4494.
https://doi.org/10.1182/blood.V110.11.4494.4494
Published: 2007
Journal Articles

Phase II Trial of the Oral mTOR Inhibitor RAD001 (Everolimus) in Relapsed and/or Refractory Waldenstrom Macroglobulinemia: Preliminary Results.

Irene M. Ghobrial, Renee Leduc, Marybeth Nelson, Xavier Leleu, Eric Jacobsen, Ann LaCasce, Daniel DeAngelo, David Fisher, Jennifer R. Brown, Robert Schlossman, Diane Warren, Jacob Soumerai, Kelly O’Connor, Nikhil Munshi, Paul Richardson, Kenneth C. Anderson, Thomas E. Witzig, Steven P. Treon
Journal: Blood
Blood (2007) 110 (11): 4496.
https://doi.org/10.1182/blood.V110.11.4496.4496
Published: 2007